Cargando…
Tall Cell Variant versus Conventional Papillary Thyroid Carcinoma: A Retrospective Analysis in 351 Consecutive Patients
Background: The aim of this retrospective study was to investigate clinical and pathological characteristics of the tall cell variant of papillary thyroid carcinoma compared to conventional variants. Methods: The clinical records of patients who underwent surgical treatment between 2009 and 2015 wer...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794904/ https://www.ncbi.nlm.nih.gov/pubmed/33379135 http://dx.doi.org/10.3390/jcm10010070 |
_version_ | 1783634318274330624 |
---|---|
author | Longheu, Alessandro Canu, Gian Luigi Cappellacci, Federico Erdas, Enrico Medas, Fabio Calò, Pietro Giorgio |
author_facet | Longheu, Alessandro Canu, Gian Luigi Cappellacci, Federico Erdas, Enrico Medas, Fabio Calò, Pietro Giorgio |
author_sort | Longheu, Alessandro |
collection | PubMed |
description | Background: The aim of this retrospective study was to investigate clinical and pathological characteristics of the tall cell variant of papillary thyroid carcinoma compared to conventional variants. Methods: The clinical records of patients who underwent surgical treatment between 2009 and 2015 were analyzed. The patients were divided into two groups: those with a histopathological diagnosis of tall cell papillary carcinoma were included in Group A, and those with a diagnosis of conventional variants in Group B. Results: A total of 35 patients were included in Group A and 316 in Group B. All patients underwent total thyroidectomy. Central compartment and lateral cervical lymph node dissection were performed more frequently in Group A (42.8% vs. 18%, p = 0.001, and 17.1% vs. 6.9%, p = 0.04). Angiolymphatic invasion, parenchymal invasion, extrathyroidal extension, and lymph node metastases were more frequent in Group A, and the data reached statistical significance. Local recurrence was more frequent in Group A (17.1% vs. 6.3%, p = 0.02), with two patients (5.7%) in Group A showing visceral metastases, whereas no patient in Group B developed metastatic cancer (p = 0.009). Conclusions: Tall cell papillary carcinoma is the most frequent aggressive variant of papillary thyroid cancer. Tall cell histology represents an independent poor prognostic factor compared to conventional variants. |
format | Online Article Text |
id | pubmed-7794904 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-77949042021-01-10 Tall Cell Variant versus Conventional Papillary Thyroid Carcinoma: A Retrospective Analysis in 351 Consecutive Patients Longheu, Alessandro Canu, Gian Luigi Cappellacci, Federico Erdas, Enrico Medas, Fabio Calò, Pietro Giorgio J Clin Med Article Background: The aim of this retrospective study was to investigate clinical and pathological characteristics of the tall cell variant of papillary thyroid carcinoma compared to conventional variants. Methods: The clinical records of patients who underwent surgical treatment between 2009 and 2015 were analyzed. The patients were divided into two groups: those with a histopathological diagnosis of tall cell papillary carcinoma were included in Group A, and those with a diagnosis of conventional variants in Group B. Results: A total of 35 patients were included in Group A and 316 in Group B. All patients underwent total thyroidectomy. Central compartment and lateral cervical lymph node dissection were performed more frequently in Group A (42.8% vs. 18%, p = 0.001, and 17.1% vs. 6.9%, p = 0.04). Angiolymphatic invasion, parenchymal invasion, extrathyroidal extension, and lymph node metastases were more frequent in Group A, and the data reached statistical significance. Local recurrence was more frequent in Group A (17.1% vs. 6.3%, p = 0.02), with two patients (5.7%) in Group A showing visceral metastases, whereas no patient in Group B developed metastatic cancer (p = 0.009). Conclusions: Tall cell papillary carcinoma is the most frequent aggressive variant of papillary thyroid cancer. Tall cell histology represents an independent poor prognostic factor compared to conventional variants. MDPI 2020-12-28 /pmc/articles/PMC7794904/ /pubmed/33379135 http://dx.doi.org/10.3390/jcm10010070 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Longheu, Alessandro Canu, Gian Luigi Cappellacci, Federico Erdas, Enrico Medas, Fabio Calò, Pietro Giorgio Tall Cell Variant versus Conventional Papillary Thyroid Carcinoma: A Retrospective Analysis in 351 Consecutive Patients |
title | Tall Cell Variant versus Conventional Papillary Thyroid Carcinoma: A Retrospective Analysis in 351 Consecutive Patients |
title_full | Tall Cell Variant versus Conventional Papillary Thyroid Carcinoma: A Retrospective Analysis in 351 Consecutive Patients |
title_fullStr | Tall Cell Variant versus Conventional Papillary Thyroid Carcinoma: A Retrospective Analysis in 351 Consecutive Patients |
title_full_unstemmed | Tall Cell Variant versus Conventional Papillary Thyroid Carcinoma: A Retrospective Analysis in 351 Consecutive Patients |
title_short | Tall Cell Variant versus Conventional Papillary Thyroid Carcinoma: A Retrospective Analysis in 351 Consecutive Patients |
title_sort | tall cell variant versus conventional papillary thyroid carcinoma: a retrospective analysis in 351 consecutive patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794904/ https://www.ncbi.nlm.nih.gov/pubmed/33379135 http://dx.doi.org/10.3390/jcm10010070 |
work_keys_str_mv | AT longheualessandro tallcellvariantversusconventionalpapillarythyroidcarcinomaaretrospectiveanalysisin351consecutivepatients AT canugianluigi tallcellvariantversusconventionalpapillarythyroidcarcinomaaretrospectiveanalysisin351consecutivepatients AT cappellaccifederico tallcellvariantversusconventionalpapillarythyroidcarcinomaaretrospectiveanalysisin351consecutivepatients AT erdasenrico tallcellvariantversusconventionalpapillarythyroidcarcinomaaretrospectiveanalysisin351consecutivepatients AT medasfabio tallcellvariantversusconventionalpapillarythyroidcarcinomaaretrospectiveanalysisin351consecutivepatients AT calopietrogiorgio tallcellvariantversusconventionalpapillarythyroidcarcinomaaretrospectiveanalysisin351consecutivepatients |